# Cantharidin Application in Molluscum Patients

> **NCT03377803** · PHASE3 · COMPLETED · sponsor: **Verrica Pharmaceuticals Inc.** · enrollment: 262 (actual)

## Conditions studied

- Molluscum Contagiosum

## Interventions

- **COMBINATION_PRODUCT:** VP-102 - Cantharidin, Topical Film Forming Solution
- **COMBINATION_PRODUCT:** Placebo -Topical Film Forming Solution without VP-102

## Key facts

- **NCT ID:** NCT03377803
- **Lead sponsor:** Verrica Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-14
- **Primary completion:** 2018-09-26
- **Final completion:** 2018-09-26
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2021-12-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03377803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03377803, "Cantharidin Application in Molluscum Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03377803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*